NanoViricides Inc. (NNVC)

[drkazmd65]

The choice to NOT pursue an Ebolacide post doing the initial cell-culture work in 2007-2008 was (IMO) an extremely smart and practical business move.

Think of it this way,.... IF NNVC had spent large amounts of time, energy and resources in the intervening time between 2008 and this Spring, when Ebola first started to re-emerge as a problem in Africa,.... how many people here (myself included) would have criticized them for going after a drug formulation that had no commercial market?

Flucide is the low-hanging fruit, with a huge market, an obvious set of target patients, and with infected populations that are easily accessable.

Yes - it would be remarkably handy from a world health perspective to have a reliable Ebolacide on hand now. But that would have been spinning the corporate wheels for the last 6 years.